Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series

Abstract

Background The prevalence of Multiple Sclerosis (MS) has been increasing worldwide and the highest prevalence ratio among Asian countries was reported in Iran. This study aims to estimate the increase in MS occurrence during more than three decades in Tehran and forecast the future condition of the disease using time series approaches for the next ten years. Methods The cross-sectional study was conducted from 1999 to 2019 based on records of MS cases from Iranian MS Society (IMSS) registry system. The prevalence was estimated using population data presented by the Statistical Centre of Iran. Through Bayesian Structural Time Series (BSTS) model, we want to predict the prevalence of familial and sporadic MS in the next ten years. . Results Among 22,421 cases with MS, 16,831 (75.1 %) were female and 5589 (24.9 %) were male. Female to male ratio was 3.0:1 and the number of familial MS cases were 2982 (13.3 %) of subjects. Female gender was less responsible for higher rate of MS in familial definition (beta = 0.020) in comparison to sporadic cases (beta = 0.034). Forecasting by BSTS revealed an increase in MS prevalence for the next ten years so that the prevalence rate for total, familial and sporadic MS respectively begins with 189.50 (183.94-195.14), 25.69 (24.97–26.45) and 163.74(159.06-168.57) in 2020 and ends with 220.84 (171.48-266.92), 30.79 (24.16–37.15), and 189.33(146.97-230.19) in 2029. Conclusions According to the findings, MS prevalence increased during three decades and it will increase over the next ten years. Tehran province is one of the regions with highest MS prevalence in Asia. The results of present study indicated that females are at higher risk for MS than males in both sporadic and familial MS.

The effect of peer education based on Pender’s health promotion model on quality of life, stress management and self-efficacy of patients with multiple sclerosis: a randomized controlled clinical trial

“…The prevalence of MS varies in different societies. According to the statistics recorded in the special diseases website of the Iranian Ministry of Health, there are approximately 70,000 MS patients in Iran, which population increases by 5000 new cases per year [ 4 ]. As a chronic, disabling illness with many consequences, MS adversely affects the quality of life and self-efficacy of the patients and exposes the patients to stress and other psycho-emotional issues [ 5 , 6 ].…”

Predicting the epidemiological trend of acute hemorrhagic conjunctivitis in China using Bayesian structural time–series model

“…There were two small peaks of incidence in 2014 and 2019. The reported incidence rate in 2014 increased by 19.11% compared with 2013, and the reported incidence rate in 2019 increased by 8.00% compared with 2018. In 2020, due to the prevention and control measures of the new coronavirus pneumonia epidemic, cases were reported significantly reduced 9 .…”

Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes

“…Multiple sclerosis (MS) is a neurological disease characterized by inflammation and degeneration of the central nervous system (CNS) [ 1 ]. In 2020, it was estimated to affect 2.8 million people globally [ 2 ], with the number expected to increase over time [ 3 , 4 ]. There are a broad range of symptoms associated with MS, and they manifest differently between patients.…”